Cardiovascular

Audio Journal of Cardiovascular Medicine: September 7th 2006

Source: World Congress of Cardiology joint meeting with European Society of Cardiology, September 2-6, 2006, Barcelona
Gilles Montalescot
Gilles Montalescot
Freek Verheugt
Freek Verheugt

Angioplasty: Four-Continent RIVIERA Study Identifies “Real World” Modifiable Factors Which Affect Outcome

REFERENCE: Abstract 3413, “Hot Line II” Session, Abstract 649
Gilles Montalescot, Pitié-Salpêtriere Hospital, Paris
Angioplasty outcomes can be improved by modifying factors identified by the 8000-patient, 23-country, prospective, observational “RIVIERA” study presented at a “Hot Line” session of the cardiology congress in Barcelona. Gilles Montalescot discussed the rôle of pre-treatment with clopidogrel, the use of statins, radial rather than femoral access, and the choice of anticoagulation. Peter Goodwin asked him about his findings.

Coagulation Choices in Elective and Primary PCI

REFERENCE: “Hot Line II” Session
Freek Verheugt, Nijmegen University, Netherlands
Amid controversy in Barcelona about the choice of anticoagulation for patients receiving angioplasty Freek Verheugt commented on the relative merits of low-molecular weight heparin and the factor 10a inhibitor fondaparinux. He gave Peter Goodwin his reactions to recommendations emerging from the RIVIERA study of angioplasty outcome determinants.

Similar Interviews

  • Audio Journal of Cardiovascular Medicine: September 6th 2006
  • REFERENCE: Abstract 1011 to 1016 Tony Gershlick, Leicester University A session entitled: “Stent Thrombosis in the Drug-Eluting Stents Era” at the Barcelona

  • Cardiovascular Medicine
  • Cardiologists and doctors whose patients have cardiovascular disease in any form receive up-to-date audio information via the audio journal of

  • Audio Journal of Cardiovascular Medicine: September 3rd 2006
  • Anthony Wierzbicki

    Post a comment

    Subscribe to Audio Medica Podcast